Olin and Huntsman to merge as OlinHuntsman

Key highlights
  • Combined 2025 revenue on a combined company basis is approximately $12.5 billion.
  • More than $400 million of identified cost synergies and integration benefits, with the majority of $300M+ realized within 24 months and an extra $100M of raw material benefits starting in 2031.
  • All-stock merger of equals: Huntsman shareholders receive 0.5476 Olin shares per Huntsman share; post-close ownership ~54.5% Olin and ~45.5% Huntsman.
  • Transaction expected to close in the first half of 2027, subject to regulatory and shareholder approvals; headquarters to be in The Woodlands, Texas.

Deal overview

Olin Corporation and Huntsman Corporation have agreed an all-stock merger of equals to form OlinHuntsman, an integrated North American chemicals company combining Olin's scale and electrochemical feedstock capabilities with Huntsman's downstream formulations and advanced materials. The combined company would have pro forma 2025 revenue of approximately $12.5 billion.

Strategic rationale

The transaction pairs upstream chlorine and caustic production with downstream polyurethane systems, formulations and advanced materials to increase chlorine optionality, improve feedstock conversion into higher-value downstream products and deepen exposure to end markets including automotive, construction and industrial applications. Winchester ammunition will remain a key business within the combined company.

Synergies and financial profile

Olin and Huntsman identified more than $400 million of total cost synergies and integration benefits, including over $300 million expected to be realized mostly within 24 months and all by the end of year three, plus an additional $100 million of raw material integration benefits beginning in 2031. The combined company also expects approximately $125 million of cash tax benefits from acceleration of net operating losses. Management says the deal preserves balance sheet strength and targets disciplined capital allocation, deleveraging, a stable dividend and reinvestment of excess cash.

Leadership, governance and logistics

Ken Lane will serve as CEO and Peter Huntsman as non-executive Chairman; Phil Lister will be CFO and Todd Slater Chief Integration Officer. The board will have ten members with equal representation. OlinHuntsman will be headquartered in The Woodlands, Texas.

Transaction mechanics and timing

The exchange ratio is 0.5476 Olin shares for each Huntsman share, producing an approximate post-close split of 54.5% Olin and 45.5% Huntsman. The transaction has unanimous board approval and is expected to close in the first half of 2027, subject to customary closing conditions and regulatory and shareholder approvals.

Source: Huntsman

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time.

Related articles

14 July 2026
Olin and Huntsman: SEC Declares S‑4 Effective for Planned Merger

SEC declared the Form S‑4 effective; special shareholder meetings set for Aug 25; closing expected H1 2027; transaction targets >$400M in synergies and broader vertical integration.

31 March 2026
Lilly to acquire Centessa Pharmaceuticals for OX2R sleep‑wake portfolio

$38/ADS cash + up to $9 CVR (max $47/sh); upfront equity ~$6.3B (CVR ~$1.5B). Lead OX2R agonist cleminorexton showed positive Phase 2a for narcolepsy and idiopathic hypersomnia. Close expected Q3

9 June 2026
GSK to acquire Nuvalent for $10.6 billion

Includes two late-stage ROS1 and ALK NSCLC inhibitors under FDA review for 2026 decisions, plus a HER2 candidate; expected to be accretive to profit from 2027 and funded by debt and cash.

29 July 2026
thyssenkrupp nucera delivers chlor-alkali plant to Chlorum Solutions in Palmeira, Brazil

Skid-mounted BM2.7 zero-gap membrane plant produces >15,000 tpy chlorine, runs on renewable electricity and follows a February commissioning of a similar unit.

17 December 2024
Chlorum Solutions USA to build first U.S. chlor-alkali plant in Casa Grande, Arizona

Small-scale $70M plant will use membrane electrolysis to make sodium hypochlorite, HCl and caustic soda for Arizona without storing liquefied chlorine, boosting local supply resilience.